¼¼°èÀÇ ·Îº¿ ¹æ»ç¼± ¼ö¼ú ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 3¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº 11.1%ÀÇ CAGR·Î È®´ëÇϸç, 2031³â¿¡´Â 7¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°èÀÇ ¾ÏȯÀÚ ¼ö´Â Àα¸ÀÇ Áõ°¡¿Í °í·ÉÈ, ¶óÀÌÇÁ½ºÅ¸ÀÏ ¿äÀÎ(Èí¿¬, ¾ËÄÚ¿Ã, ¿µ¾ç ºÒ·®, ºñ¸¸, ½ºÆ®·¹½º) µîÀÇ ÀÌÀ¯¿¡ ÀÇÇØ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. WHO´Â »õ·Î¿î ¾ÏȯÀÚ°¡ 3,500¸¸ ¸íÀ» ³Ñ¾î 2022³âÀ¸·ÎºÎÅÍ 77% Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù.
¹æ»ç¼± Ä¡·á´Â ¾ÏÀÇ ±Ùº»ÀûÀÎ Ä¡·áÀÇ 40%¿¡ ±â¿©Çϰí ÀÖÁö¸¸, Àü ¼¼°è ÀÌ¿ë·üÀº ¾ÆÁ÷ 50% ¹Ì¸¸À¸·Î ¼ºÀåÀÇ ¿©Áö°¡ ÀÖ½À´Ï´Ù.
2024³â ½ÃÀå Á¡À¯À²Àº ºÏ¹Ì°¡ °¡Àå Å©°í ¼À¯·´ÀÌ ±× µÚ¸¦ À̾ú½À´Ï´Ù. ¾ÆÇÁ¸®Ä«ÀÇ Á¡À¯À²Àº °¡Àå ÀÛÁö¸¸ Å« ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ½ÃÀå ¸ÅÃâ ±âÁØÀ¸·Î´Â °¡Àå ´À¸° ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇÁö¸¸, ½Ã¼ú °Ç¼ö ±âÁØÀ¸·Î´Â °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ¸ðµç Áö¿ªÀº ¿¹Ãø ±â°£ Áß µÎ ÀÚ¸´¼ö CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°èÀÇ ·Îº¿ ¹æ»ç¼± ¼ö¼ú ½Ã½ºÅÛ ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ °³¿ä¿Í ½ÃÀå ºÐ¼®°ú ¿¹Ãø, ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ, °æÀï ±¸µµ µîÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù.
The global robotic radiosurgery system market was valued at $350 million in 2024 and is projected to grow at a CAGR of 11.1%, reaching $720 million by 2031.
The market is segmented into:
Market Insights & Data Coverage
Market Trends & Growth Drivers
* Global cancer cases are rising due to:
* Population growth & aging
* Lifestyle factors (smoking, alcohol, poor nutrition, obesity, stress)
* WHO projects over 35 million new cancer cases, a 77% increase from 2022.
* Radiation therapy contributes 40% to curative cancer treatments, but global utilization remains under 50%, indicating room for growth.
Challenges & Market Limitations
Geographic Trends & Growth Projections
Market Share Insights
Leading Competitors & Key Developments
1 Accuray - Market Leader
* Offers CyberKnife(R), a leading robotic radiosurgery system.
* Partnership with Brainlab (2020) expanded CyberKnife(R)'s neuro-radiosurgery applications.
* Partnership with Limbus AI Inc. (2022) aimed at integrating AI-powered radiation therapy solutions.
2 Zap Surgical - Emerging Competitor
* Zap-X(R) Gyroscopic Radiosurgery(R) system is an innovative, self-shielded radiotherapy device.
* Focuses on treating brain, head, and neck conditions.
* More affordable than CyberKnife(R), with an estimated price below $2 million.
Market Segmentation Summary
Global Research Scope
* North America (U.S., Canada)
* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)
* Western Europe (Germany, France, U.K., Spain, Italy)
* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)
* Middle East (Saudi Arabia, UAE, Israel)
* Asia-Pacific (China, Japan, India, South Korea, Australia)
* Africa (South Africa, Egypt, Nigeria, Kenya)
Quantitative Coverage
Qualitative Coverage
Data Sources